Swedish Industrial Development Fund

Heart failure is the leading cause of hospitalization and death globally. AnaCardio is a biotech company in the clinical stage that is developing a small molecule pharmaceutical with a novel potential first-in-class treatment option. Based on world-leading research from Karolinska Institutet leading to the discovery of a disease-modifying mechanism they provide a unique approach with the potential to save millions of lives.

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore venture capital firm profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Swedish Industrial Development Fund.

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Heart failure is the leading cause of hospitalization and death globally. AnaCardio is a biotech company in the clinical stage that is developing a small molecule pharmaceutical with a novel potential first-in-class treatment option. Based on world-leading research from Karolinska Institutet leading to the discovery of a disease-modifying mechanism they provide a unique approach with the potential to save millions of lives.

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.